학술논문
Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways
Document Type
Article
Author
Source
In: Translational Oncology . (Translational Oncology, February 2024, 40)
Subject
Language
English
ISSN
19365233